Pharmaceutical firm plans to offer additional shares
Mekophar Chemical and Pharmaceutical Joint Stock Co (coded MKP) has lately approved the 2011 year plan with targeted revenue of 950 billion dong, pre-tax profit of 92 billion dong, equivalent to that of 2010. The company also planned to offer additional shares at 20,000 dong per share.
Huynh Thi Lan, chair of management board in Mekophar stated that the company cannot increase the sales price for its products at present due to the fact that one third of the products are included in the price-stabilisation lists from March 2011 to June 2012. Therefore, the company cannot raise the sales price despite increasing trend in prices for input materials.
The company has already submitted application letter for adjusting price for some products.
Tags: Vietnam business news